TrialNature medicine2021

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.

Kathryn E Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.